Press Releases

Press Releases

January 9. 2017
Amended licensing agreement with long-term partner allows Quanterix to continue innovation and commercialization within its expanding fields
June 22, 2017
CEO and Chairman, Kevin Hrusovsky, will be hosting a webinar on the use of ultrasensitive biomarker assays to enable precision health, with a specialty focus on concussion and traumatic brain injury (TBI) detection and diagnostics.  Hrusovsky will be joined by Dr. Jessica Gill, Investigator at…
Business Wire| November 27, 2017
Quanterix Corporation today announced the commencement of the initial public offering of shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “Commission”).
CAMBRIDGE, MA – December 1, 2010 – Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company’s Board as Executive Chairman. Dr. Madaus brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as President, Chairman…
CAMBRIDGE, MA – August 19, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn’s…
LEXINGTON, MA – April 23, 2012 – Quanterix Corporation, the leading developer of high definition diagnostic tools based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today that it has moved to a newly renovated facility in Lexington, MA to accommodate the company's…
LEXINGTON, Mass., August 15, 2013 – Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Paul Meister to its Board of Directors.
Lexington--(BUSINESS WIRE)– May 5, 2014 Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it has been selected as a finalist for Red Herring's Top 100 North America award, a prestigious…
LEXINGTON, MA – March 4, 2015 Quanterix Corporation, a leader in ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Chief Executive Officer (“CEO”). Mr. Hrusovsky will continue to serve as Executive Chairman of its Board…
LEXINGTON, MA – July 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it will be presenting at The Alzheimer’s Association International Conference (AAIC), July 18-23…